vs
Side-by-side financial comparison of Esperion Therapeutics, Inc. (ESPR) and LendingClub Corp (LC). Click either name above to swap in a different company.
LendingClub Corp is the larger business by last-quarter revenue ($252.3M vs $168.4M, roughly 1.5× Esperion Therapeutics, Inc.). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs 15.9%). Over the past eight quarters, LendingClub Corp's revenue compounded faster (16.1% CAGR vs 10.6%).
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
LendingClub Corporation is an American financial services company headquartered in San Francisco, California. It was the first peer-to-peer lender to register its offerings as securities with the Securities and Exchange Commission (SEC), and to offer loan trading on a secondary market. At its height, LendingClub was the world's largest peer-to-peer lending platform. The company reported that $15.98 billion in loans had been originated through its platform up to December 31, 2015.
ESPR vs LC — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $168.4M | $252.3M |
| Net Profit | — | $51.6M |
| Gross Margin | — | — |
| Operating Margin | 50.6% | — |
| Net Margin | — | 20.5% |
| Revenue YoY | 143.7% | 15.9% |
| Net Profit YoY | — | 341.0% |
| EPS (diluted) | $0.32 | $0.44 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $252.3M | ||
| Q4 25 | $168.4M | $266.5M | ||
| Q3 25 | $87.3M | $266.2M | ||
| Q2 25 | $82.4M | $248.4M | ||
| Q1 25 | $65.0M | $217.7M | ||
| Q4 24 | $69.1M | $217.2M | ||
| Q3 24 | $51.6M | $201.9M | ||
| Q2 24 | $73.8M | $187.2M |
| Q1 26 | — | $51.6M | ||
| Q4 25 | — | — | ||
| Q3 25 | $-31.3M | $44.3M | ||
| Q2 25 | $-12.7M | $38.2M | ||
| Q1 25 | $-40.5M | $11.7M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-29.5M | $14.5M | ||
| Q2 24 | $-61.9M | $14.9M |
| Q1 26 | — | — | ||
| Q4 25 | 50.6% | 18.8% | ||
| Q3 25 | -11.4% | 21.5% | ||
| Q2 25 | 8.6% | 21.7% | ||
| Q1 25 | -34.0% | 7.2% | ||
| Q4 24 | -6.4% | 5.1% | ||
| Q3 24 | -31.0% | 8.9% | ||
| Q2 24 | 3.5% | 10.4% |
| Q1 26 | — | 20.5% | ||
| Q4 25 | — | — | ||
| Q3 25 | -35.9% | 16.6% | ||
| Q2 25 | -15.4% | 15.4% | ||
| Q1 25 | -62.2% | 5.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | -57.2% | 7.2% | ||
| Q2 24 | -83.9% | 8.0% |
| Q1 26 | — | $0.44 | ||
| Q4 25 | $0.32 | $0.36 | ||
| Q3 25 | $-0.16 | $0.37 | ||
| Q2 25 | $-0.06 | $0.33 | ||
| Q1 25 | $-0.21 | $0.10 | ||
| Q4 24 | $-0.14 | $0.08 | ||
| Q3 24 | $-0.15 | $0.13 | ||
| Q2 24 | $-0.33 | $0.13 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.9M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-302.0M | $1.5B |
| Total Assets | $465.9M | $11.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $167.9M | — | ||
| Q3 25 | $92.4M | — | ||
| Q2 25 | $86.1M | — | ||
| Q1 25 | $114.6M | — | ||
| Q4 24 | $144.8M | — | ||
| Q3 24 | $144.7M | — | ||
| Q2 24 | $189.3M | — |
| Q1 26 | — | — | ||
| Q4 25 | — | $0 | ||
| Q3 25 | — | $0 | ||
| Q2 25 | — | $0 | ||
| Q1 25 | — | $0 | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | $1.5B | ||
| Q4 25 | $-302.0M | $1.5B | ||
| Q3 25 | $-451.4M | $1.5B | ||
| Q2 25 | $-433.5M | $1.4B | ||
| Q1 25 | $-426.2M | $1.4B | ||
| Q4 24 | $-388.7M | $1.3B | ||
| Q3 24 | $-370.2M | $1.3B | ||
| Q2 24 | $-344.2M | $1.3B |
| Q1 26 | — | $11.9B | ||
| Q4 25 | $465.9M | $11.6B | ||
| Q3 25 | $364.0M | $11.1B | ||
| Q2 25 | $347.1M | $10.8B | ||
| Q1 25 | $324.0M | $10.5B | ||
| Q4 24 | $343.8M | $10.6B | ||
| Q3 24 | $314.1M | $11.0B | ||
| Q2 24 | $352.3M | $9.6B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.00× | ||
| Q3 25 | — | 0.00× | ||
| Q2 25 | — | 0.00× | ||
| Q1 25 | — | 0.00× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $45.2M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $45.2M | $-2.7B | ||
| Q3 25 | $-4.3M | $-770.8M | ||
| Q2 25 | $-31.4M | $-713.1M | ||
| Q1 25 | $-22.6M | $-339.3M | ||
| Q4 24 | $-35.0M | $-2.6B | ||
| Q3 24 | $-35.3M | $-669.8M | ||
| Q2 24 | $-7.2M | $-932.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | $-2.9B | ||
| Q3 25 | — | $-791.8M | ||
| Q2 25 | — | $-803.8M | ||
| Q1 25 | — | $-352.3M | ||
| Q4 24 | — | $-2.7B | ||
| Q3 24 | $-35.5M | $-682.3M | ||
| Q2 24 | $-7.3M | $-945.3M |
| Q1 26 | — | — | ||
| Q4 25 | — | -1076.0% | ||
| Q3 25 | — | -297.4% | ||
| Q2 25 | — | -323.5% | ||
| Q1 25 | — | -161.8% | ||
| Q4 24 | — | -1237.8% | ||
| Q3 24 | -68.7% | -338.0% | ||
| Q2 24 | -9.9% | -504.9% |
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | 52.7% | ||
| Q3 25 | 0.0% | 7.9% | ||
| Q2 25 | 0.0% | 36.5% | ||
| Q1 25 | 0.0% | 6.0% | ||
| Q4 24 | 0.0% | 25.0% | ||
| Q3 24 | 0.3% | 6.2% | ||
| Q2 24 | 0.1% | 6.9% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | -17.41× | ||
| Q2 25 | — | -18.68× | ||
| Q1 25 | — | -29.07× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -46.33× | ||
| Q2 24 | — | -62.57× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
LC
Segment breakdown not available.
